Senores Pharmaceuticals Ltd
Company Profile
Business description
Senores Pharmaceuticals Ltd is a research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of the USA, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Its strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing the company as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, It strategically identifies commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets.
Contact
Ambali Bopal Road
1101 to 1103, 11th floor, South Tower, ONE 42
Opposite Jayantilal Park
AhmedabadGJ380054
INDT: +91 7929999857
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2026
Employees
145
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,961.70 | 8.20 | -0.10% |
| CAC 40 | 7,329.97 | 5.43 | -0.07% |
| DAX 40 | 21,311.02 | 57.32 | 0.27% |
| Dow JONES (US) | 39,669.39 | 699.57 | -1.73% |
| FTSE 100 | 8,275.60 | 26.48 | 0.32% |
| HKSE | 21,056.98 | 409.29 | -1.91% |
| NASDAQ | 16,307.16 | 516.01 | -3.07% |
| Nikkei 225 | 33,920.40 | 347.14 | -1.01% |
| NZX 50 Index | 12,055.28 | 12.64 | -0.10% |
| S&P 500 | 5,275.70 | 120.93 | -2.24% |
| S&P/ASX 200 | 7,758.90 | 2.80 | -0.04% |
| SSE Composite Index | 3,276.00 | 8.34 | 0.26% |